NSECertificate under SEBI (Depositories and Participants) Regulations, 201815 Jul 2026 · 15 Jul 2026, 06:50 pm
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Global Health Limited · MEDANTA
✦ AI SummaryESG
Global Health Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, regarding the Reconciliation of Share Capital Audit Report for the quarter ended June 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Global Health Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018.
Attachments (1)
📄pdf
Download →
MEDANTA21_15072026184643_GHLRECOQUARTER30JUNE2026Signed.pdf
View document text
Limited
July 15, 2026
Ref: - GHL/2026-27/EXCH/30
The General Manager The Manager
Dept. of Corporate Services Listing Department
BSE Limited, National Stock Exchange of India Limited
P J Towers, Dalal Street, Exchange Plaza, C-1, Block G,
Mumbai - 400 001 Bandra Kurla Complex,
Bandra (E), Mumbai - 400 051
Scrip Code: 543654 Symbol: MEDANTA
Sub: Certificate under Regulation 76 of SEBI (Depositories and Participants) Regulations,
2018
Dear Sir(s),
Please find attached herewith the Certificate issued by M/s Mukesh Agarwal & Co., Practicing
Company Secretary, dated July 14, 2026, regarding the Reconciliation of Share Capital Audit
Report, for the quarter ended June 30, 2026.
This is for your information and record.
Thanking you,
Yours Faithfully,
For Global Health Limited
Rahul Ranjan
Company Secretary & Compliance Officer
M. No. A17035
Encl: a/a
Regd. Office: E-18, Defence Colony, New Delhi 110024, Ph No.011- 44114411 www.medanta.org, info@medanta.org, CIN: L85110DL2004PLC128319
MUKESH AGARWAL & CO.
(COMPANY S~CRETARIES)
3029, Sant Nagar, Rani Bagh, Opp. M2K Pitampura, Delhi-110034
Tel. No. : 011-42458279, 47060535 Email: magarwalandco@gmail.com
l Y• 01 • 2. o2b
Ref. No. Dated .............................. .
Reconciliation of Share Capital Audit
According to our examination of all relevant books, registers, forms, documents and papers
pertaining to the equity shares of GLOBAL HEALTH LIMITED (hereinafter referred to as the
"Company") having its registered office at E-18, Medanta-Mediclinic, Defence colony, New
Delhi 110024 as maintained by the Company and information provided to us by Kfin
Technologies Limited, the Company's Registrar and Share Transfer Agent, having their office at
Selenium Build_ing, Tower-B, Plot No 31 & 32, Financial District, Nanakramguda,
Serilingampally, Rangareddi, Hyderabad, Telangana-500032, in respect of Reconciliation of Share
Capital Audit as per Regulation 76 of Securities and Exchange Board of India (Depositories and
Participants) Regulations, 20 I 8, we report as under:-
1. For Quarter ended June 30, 2026
2. ISIN INE474O01031
3. Face Value Rs. 2/- oer Equity Share
4. Name of the Company GLOBAL HEALTH LIMITED
CIN L851 I0DL2004PLCl28319
5. Registered Office Address E-18, Medanta-Mediclinic. Defence Colony,
New Delhi-I I 0024
6. Correspondence Address Medanta-The Medicity. Sector 38, Gurugram,
Harvana-12200 I
7. Telephone No. & Fax No. Tel No. - 0124- 4834060
8. Email Address compliance@medanta.org
Website httos://wwv1.medanta.orn:
9. Name of the Stock Exchange where the BSE Limited, Mumbai: and
Companies Securities are listed National Stock Exchange of India Limited,
Mumbai
I 0. Issued Capital Number of Shares % of Total
(Shares of Rs. 2/- each) Issued Capital
26,88,7 1,782 100%
11. Listed Capital 26,88,67,7 82 99.99%
12. Shares held in dematerialized form in l,81,11.621 6.73%
CDSL
13. Shares held in dematerialized form in 25,07,56.159 93.26%
NSDL
14. Physical 2 0.00%
15. Total No of Shares (12+13+14) 26,88,67,7 82 99.99%
Page 1 Of4
16. Reasons for difference, if any, between The Company allotted 4,000 equity shares on
( 10 & 1 1) ,( 1 I & 15) June 24, 2026 under Part A of the GHL LTIP
Reasons for difference, if any, between Scheme, 2024. The listing application and
(10 & 15) corporate action approval were pending as at
the close of the quarter enq_ed June 30, 2026.
p..GARvz;_
C . 3851 '0
Page 2 0/4
17. Certifying the details of changes in share capital during the quarter under consideration as
per table below:-
Particulars No of Applied/ Listing on Whether Whether In-
Shares Not Stock intimated intimated Principle
applied Exchanges to CDSL to NSDL approval
for Listing pending
for SE
(specify
name)
Allotment of 61,500 Applied Listed on Yes Yes No
Equity shares on BSE
April 22, 2026, Limited and
pursuant to National
options exercised Stock
by employees, in Exchange
pursuance of Part of India
A of GHL Limited.
Employee
Long Term Share
Based Incentive
Plan, 2024.
Allotment of 15,900 Applied Listed on Yes No1 No
Equity shares on BSE
May 23, 2026, Limited and
pursuant to National
options exercised Stock
by employees, in Exchange
pursuance of Part of India
A of GHL Limited.
Employee
Long Term Share
Based Incentive
Plan, 2024.
Allotment of 4,000 Not No3 No4 No No
Equity shares on applied2
June 24, 2026,
pursuant to
options exercised
by employees, -in
pursuance of Part
A of GHL
Employee
Long Term Share
Based Incentive
Plan, 2024.
1T he Company submitted the intimation to NSDL after the closure oft he quarter ended June 30, 2026.
2 The Company applied to NSEIBSEfor listing of4 ,000 equity shares after the closure oft he quarter ended
June 30, 2026.
3 Listing approval from NSEIBSEfor the aforesaid 4,000 equity shares was received on July 09, 2026.
4 The Company intimated CDSL on July OJ, 2026, and the said shares were credited on July 07, 2026.
Page 3 Of4
18. Register of Members is updated (Yes/No) Yes
(if not update, upto which date)
19. Reference of previous quarter with Nil
regards to excess dematerialized shares, if
20. Has the Company resolved the matter Not Applicable
mentioned in point no 19 above in the
current quarter? if not reason whv
21. Mentioned the total no. of requests, if any, NIL
confirmed after 21 days and the total no.
of requests pending beyond 21 days with
the reason for delay.
Total no ofDEMAT request No of request No of shares Reason for delay
Confirmed after 21 days NIL NIL NIL
Pending for more than 21 days NIL NIL NIL
22. Name, Telephone & Fax No of the Mr. Rahul Ranjan
Compliance officer of the Company (Company Secretary & Compliance Officer)
Tel No. -0124-4834060
23. Name, Address, Telephone & Fax No., CS. MUKESH KUMAR AGARWAL
Regn No. of the Certifying CS C.P. No. 3851
Mis Mukesh Agarwal & Co;
(Company Secretarie!>)
3029, Sant Nagar, Rani Bagh, New Delhi-
110034
Tel No:-011-42458279
24. Appointment of Common Registry for Mis KFIN TECHNOLOGIES LIMITED
Share Registry work. If yes (name & Selenium Building, Tower-B, Plot No. 31 &
address) 32, Financial District, Nanakramguda,
Serilingampally,
Rangareddi, Hyderabad, Telangana - 500032
Tel No. : 1800 309 400 I
. E-mail Id : einward.ris(a)ktintech.com
Website: www.kfintech.com
25. Any other details that the auditor may like N.A.
to provide (e.g. BIFR Company, delisting
from, company change its name.)
For Mukesh Agarwal & Co
(Compa ........- --
Date: 14.07.2026 Mukes I umar
Place: Delhi Members/zip Number:
C.P. No-3851
UDIN: F005991H000826030
Page 4 Of4